(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 4.98% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.78%.
Tilray Brands's revenue in 2025 is $821,309,000.On average, 5 Wall Street analysts forecast TLRY's revenue for 2026 to be $965,470,844,191, with the lowest TLRY revenue forecast at $939,852,704,546, and the highest TLRY revenue forecast at $1,000,040,695,660. On average, 3 Wall Street analysts forecast TLRY's revenue for 2027 to be $1,008,195,623,694, with the lowest TLRY revenue forecast at $990,697,195,120, and the highest TLRY revenue forecast at $1,040,110,996,565.
In 2028, TLRY is forecast to generate $1,044,127,931,426 in revenue, with the lowest revenue forecast at $1,043,852,798,902 and the highest revenue forecast at $1,044,403,063,951.